HB 989 modifies how income is calculated for elderly individuals seeking state assistance. It prohibits including rental income from a portion of an individual's primary residence (e.g., renting a room) when determining eligibility for state tax credits, housing assistance, or medical assistance programs. The Department of Aging must review all relevant programs to confirm applicability and notify administering agencies if the rule applies. This change directly affects elderly Marylanders who rely on state assistance programs with income-based eligibility requirements. The law takes effect July 1, 2026.
Tags
Seniors
SB 579 requires Maryland counties with volunteer fire companies to provide no-cost preventive cancer screenings to volunteer firefighters, based on guidelines from the International Association of Fire Fighters. Volunteer fire companies must maintain and annually submit updated lists of their members to the county, which must then keep these records. Counties can meet this requirement by offering annual exams including cancer screenings or applying for specific grants to fund innovative screening technologies. The bill directly affects volunteer firefighters and counties, creating a structured process for access to preventive care without cost to the firefighters.
HB 1565 requires Maryland’s State Employee and Retiree Health and Welfare Benefits Program to include an obesity treatment and management program for state employees. It also mandates that private health insurers, nonprofit health plans, and health maintenance organizations cover evidence-based obesity treatment - including FDA-approved medications, metabolic/bariatric surgery, and CDC-approved behavioral programs - for individuals diagnosed with obesity, diabetes, or related conditions. The program must be developed with the Secretary of Health and follow the same coverage rules applied to other chronic diseases, avoiding stricter requirements. This bill directly affects state employees and covered individuals with qualifying health conditions by expanding access to medically necessary obesity care.
HB 1292 requires child advocacy centers in Maryland to ensure all health care professionals providing medical or mental health services are properly licensed or certified and work within their scope of practice. It mandates that centers establish a "continuity of care plan" to notify families when providers change, including contact information for both new and former providers, and allows former providers to assist with care transitions per professional standards. Centers must report specific violations to health occupations boards or the Governor’s Office of Crime Prevention and Policy, and the Governor’s Office must publish annual data about child advocacy centers online. This bill directly affects child advocacy centers, their health care staff, and the children and families receiving services at these centers.
HB 1153 prohibits health insurers, nonprofit health service plans, HMOs, and managed care organizations in Maryland from unilaterally lowering medical claim payments (downcoding) without clinical justification. The bill requires these entities to notify providers within 30 days if they intend to downcode, including specific reasons, references to clinical guidelines, and the original vs. revised codes. It bans practices like downcoding based solely on diagnosis codes, using AI without reviewing medical records, or targeting providers treating complex conditions, and mandates emergency claims be downcoded based on documented symptoms - not final diagnoses. A downcoding decision resulting in nonpayment is treated as a coverage denial, allowing providers to appeal under existing law.
SB 495 requires Maryland's Department of Health to add Gaucher disease screening to the state's mandatory newborn screening program. This affects all newborns in Maryland, as the bill mandates screening for Gaucher disease alongside other hereditary disorders under existing law. The key mechanism is amending Section 13-111 of Maryland's health code to explicitly include Gaucher disease in the list of conditions screened for, effective October 1, 2026. The bill does not alter funding or reporting procedures but directly expands the scope of the current newborn screening system to cover this specific genetic condition.
HB 740 requires every public school in Maryland to hire a full-time, state-licensed therapist who provides mental health services during school hours. This directly affects all public schools and their students, mandating access to licensed mental health support as part of school-based services. The bill specifies therapists must be certified by the State Board of Professional Counselors and Therapists and replaces existing language in the education code. It takes effect July 1, 2026.
SB 504 prohibits businesses from selling consumer personal data to buyers who intend to use it for immigration enforcement. It defines "sensitive data" to include immigration status, racial origin, health information, and sexual orientation, requiring businesses to handle such data more carefully. The bill also mandates public record custodians to prevent unauthorized disclosure - especially for immigration enforcement - and requires message switching systems to implement access controls. These changes aim to strengthen privacy protections for Maryland residents while modifying existing data privacy laws in the state code.
SB 915 requires individuals performing limited X-ray procedures (such as chest, spine, and limb imaging) in Maryland to register with the State Board of Physicians. It restricts these operations to non-invasive X-rays only (excluding CT scans, mammography, or fluoroscopy) and mandates 115 hours of specialized training plus 6 months of clinical experience. The bill also establishes disciplinary procedures for violations and allows physician assistants to perform X-ray duties under physician supervision, while updating rules for cardiovascular specialists and medical graduates. This directly affects medical staff, radiologic technicians, and physician assistants conducting basic X-ray services in clinical settings.
SB 527 establishes Maryland's Ibogaine Clinical Research Grant Program to fund clinical trials on ibogaine for treating opioid use disorder and other neurological conditions. The program provides up to three annual grants to eligible Maryland-based research institutions with neuroscience expertise, requiring matching funds equal to the grant amount. Funding comes from the Opioid Restitution Fund ($500,000 annually for fiscal years 2028-2030), administered by the Department of Health in consultation with the Department of Veterans and Military Families. Institutions must conduct FDA-reviewed trials, submit quarterly progress and financial reports, and report annually to the General Assembly on grant usage and trial outcomes. The bill directly affects research institutions, veterans (via the veterans mental health focus), and the Opioid Restitution Fund.
